Medvance
Medvance is a European healthcare consultancy group providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies across nine European countries via an integrated network of locally grounded member firms.
- Company typePrivate
- Founded2017
- HeadquartersParis, France
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Medvance does
Medvance is a European healthcare consultancy group headquartered in Paris, France, providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies. Founded in 2017 and operating under the French SARL legal entity Nextep (established 1999 by Guillaume Bouchara), the firm is structured as an integrated network of locally grounded member firms spanning nine European markets: France, Italy, the United Kingdom, Germany, Spain, Belgium, Portugal, the Netherlands, and Luxembourg. The 80-person team enables clients to contract with MEDVANCE as a single legal entity while accessing country-specific expertise through member firms including Nextep (France), Intexo Società Benefit (Italy), and Remap Consulting (UK).
The company delivers two core service lines. Market Access Services encompass European HTA support, strategic pricing advice, local HTA submission and negotiation, reimbursement submissions, health economics analyses (systematic literature reviews, network meta-analyses), clinical engagement, advisory board facilitation, payer research, real-world data studies, and medical writing. Public Affairs Services cover health policy advocacy, political influencing, patient advocacy, stakeholder outreach, campaign and coalition building, and policy intelligence and monitoring. Delivery is anchored by senior partners with 20+ years of healthcare experience, including prior roles at Pfizer, Ferring Pharmaceuticals, GSK, IMS Consulting, and Ambrosetti.
Medvance generates revenue through professional services consulting engagements on a B2B quote-based pricing model, selling to enterprise clients across pharmaceutical, biotech, and medical device verticals. The go-to-market motion is direct enterprise field sales, supplemented by thought leadership at industry conferences (ISPOR Europe, BIO International), peer-reviewed publications and posters, and a LinkedIn presence. The firm is privately held with no disclosed external funding or M&A activity in the input data.
Medvance firmographics
Firmographics- Name
- Medvance
- Legal name
- Nextep
- Website
- https://medvance.eu
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Medvance is a European healthcare consultancy group providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies across nine European countries via an integrated network of locally grounded member firms.
- Ownership category
- akta.pro rank
Medvance industry classification
Industry- Product category
- Healthcare Market Access Consulting
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)
Keywords
Where Medvance is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Medvance business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Professional Services Consulting: Provides consulting services for market access, HTA support, pricing advice, and public affairs for pharmaceutical, biotech and medical device companies across European markets.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Medvance product offering
Product offeringCore offering
Medvance is a European-wide consultancy group providing market access and public affairs consulting services to pharmaceutical, biotechnology and medical device companies. Market Access services cover European HTA support, access strategy, pricing advice, reimbursement submission, health economics, systematic literature review, network meta-analysis and real world data studies. Public Affairs services cover health policy advocacy, campaign building, patient advocacy and stakeholder outreach across nine European markets through a network of locally grounded member firms.
Product overview
Medvance is a European-wide consultancy group that offers two primary service offerings: Market Access Services and Public Affairs Services. The Market Access Services provide comprehensive support including European HTA support, strategic pricing advice, reimbursement submission, health economics, and real world data studies. The Public Affairs Services focus on health policy, political influencing, patient advocacy, and stakeholder outreach. These services work together to address the market access and public affairs needs of pharmaceutical, biotech, and medical devices companies across European markets.
Differentiator
Problem solved
Functional benefit
Products and services
- Market Access Services
Companies that use Medvance
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Medvance technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Medvance partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- NextepcoreParent legal entity and founding member of MEDVANCE. Based in Paris, provides market access and public affairs consultancy services. Guillaume Bouchara founded Nextep in 1999 and serves as Publication Director.
- Intexo Società BenefitcoreItalian member firm of MEDVANCE network. Mariangela Prada serves as CEO and Partner at Intexo, bringing 20 years of healthcare market access experience.
- Remap ConsultingcoreUK-based member firm. Graham Foxon co-founded Remap Consulting in 2014, specializing in pricing, health economics and market access optimization with over 20 years pharmaceutical experience.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Medvance competitors and assessment
Company assessmentDirect peers
- Putnam Associates: Specialist consulting firm focused exclusively on biopharma market access, pricing and commercial strategy. Highly comparable to Medvance in service scope and customer base, with deeper US presence and similar EU mid-cap client focus.
- Valid Insight: UK-based market access and pricing consultancy serving pharma, biotech and medtech with EU and global coverage. Direct niche peer competing for the same HTA, pricing and value communication mandates Medvance serves.
- CBPartners: Specialist pricing, market access and HEOR consultancy serving pharma and biotech globally. Closely comparable service mix to Medvance, with comparable scale and a similar focus on cross-border pricing and HTA strategy engagements.
- LSC Life Sciences Consultants: Independent European consulting firm providing market access, HTA and pricing services to pharma and medtech. Comparable boutique competitor in size and European focus, often bidding against Medvance on EU market access work.
- Dolon: European specialist market access and pricing consultancy focused on pharma and medtech across EU markets. Highly comparable boutique competitor to Medvance with similar customer verticals and cross-country delivery model.
- PRMA Consulting: Global market access and pricing consultancy with strong European presence, providing HTA, health economics and value communication services. Directly comparable in customer base, service offering and EU market focus.
Broad incumbents
- Charles River Associates (CRA): CRA's Life Sciences practice provides pricing, market access, HEOR and commercial strategy to global pharma. A direct competitor for EU HTA and pricing engagements, though CRA covers a broader range of industries and services beyond healthcare.
- Evidera: PPD/Evidera is a dedicated HEOR, market access and real-world evidence consultancy serving pharma and biotech across Europe and globally. Directly competes with Medvance on HTA submissions, HEOR modeling and RWE studies, now operating under Thermo Fisher.
- McKinsey & Company (Pharma Practice): Top-tier strategy consultancy with a dedicated pharma/biotech practice advising on market access, pricing and public affairs at the executive level. Larger and broader than Medvance, but competes for the same senior pharma strategy budgets.
- IQVIA: Global CRO and healthcare consulting giant offering HEOR, market access, HTA and real-world evidence services to pharma. Overlaps directly with Medvance's market access offering but as part of a much broader portfolio spanning clinical, commercial and technology services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Medvance social profiles
Digital presenceMedvance compliance and trust
Trust signalCompliance2 records
Medvance financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medvance leadership team
Management profileNumber of profiles
Profiles3 records
Medvance funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medvance M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medvance
What does Medvance do?
Medvance is a European-wide consultancy group providing market access and public affairs consulting services to pharmaceutical, biotechnology and medical device companies. Market Access services cover European HTA support, access strategy, pricing advice, reimbursement submission, health economics, systematic literature review, network meta-analysis and real world data studies. Public Affairs services cover health policy advocacy, campaign building, patient advocacy and stakeholder outreach across nine European markets through a network of locally grounded member firms.
Is Medvance a public or private company?
Medvance is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medvance founded?
Medvance was founded in 2017. It employs 51 to 100 people.
Where is Medvance based?
Medvance is headquartered in Paris, France, in the Europe region.
How does Medvance make money?
One revenue line is on record: professional Services Consulting.
Who are Medvance's main competitors?
Direct peers on record are Putnam Associates, Valid Insight, CBPartners, LSC Life Sciences Consultants, Dolon and PRMA Consulting. Broad incumbents are Charles River Associates (CRA), Evidera, McKinsey & Company (Pharma Practice) and IQVIA.
Does Medvance have an API?
No public API is recorded for Medvance.
What industry is Medvance in?
Medvance's product category is Healthcare Market Access Consulting. Its primary akta.pro industry code is HLAIAKAL, Access Policy, Advocacy & Stakeholder Management. Its SIC code is 8000.